Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Active rPMS plus rehabilitation vs sham rPMS plus rehabilitation Lower limb function · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS only vs sham rPMS Upper limb function · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs sham rPMS plus rehabilitation Muscle strength · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs sham rPMS plus rehabilitation Death · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs rehabilitation only Activities of daily living (ADLs) · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs rehabilitation only Upper limb function · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs rehabilitation only Lower limb function · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs rehabilitation only Spasticity (elbow) · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs rehabilitation only Spasticity (wrist) · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs rehabilitation only Muscle strength · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS plus rehabilitation vs rehabilitation only Death · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS only vs sham rPMS Lower limb function · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS only vs sham rPMS Spasticity (elbow) · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS only vs sham rPMS Spasticity (wrist) · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS only vs sham rPMS Death · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS only vs no intervention Activities of daily living (ADLs) · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Active rPMS only vs no intervention Upper limb function · people with stroke Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke (2022) · Cochrane | no estimate extracted | NR | No studies |
Turning position vs supine under phototherapy Need for exchange transfusion · term and preterm neonates with hyperbilirubinaemia Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia (2022) · Cochrane | no estimate extracted | NR | No studies |
Turning position vs supine under phototherapy Bilirubin‐induced neurological damage (BIND) · term and preterm neonates with hyperbilirubinaemia Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia (2022) · Cochrane | no estimate extracted | NR | No studies |
Turning position vs supine under phototherapy Sudden infant death syndrome (SIDS) · term and preterm neonates with hyperbilirubinaemia Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia (2022) · Cochrane | no estimate extracted | NR | No studies |
Combined steroid and antibiotic therapy vs antibiotics alone Outcomes* · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection) Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure (2022) · Cochrane | no estimate extracted | NR | No studies |
Combined steroid and antibiotic therapy vs antibiotics alone Improvement in visual acuity at 3 months' · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection) Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure (2022) · Cochrane | no estimate extracted | NR | No studies |
Combined steroid and antibiotic therapy vs antibiotics alone Costs associated with the interventions at 3 months' · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection) Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure (2022) · Cochrane | no estimate extracted | NR | No studies |
Water, sanitation, and hygiene (WASH) intervention vs no WASH intervention Outcome (design) · children and adults Interventions to improve water, sanitation, and hygiene for preventing soil‐transmitted helminth infection (2022) · Cochrane | no estimate extracted | NR | No studies |
Water, sanitation, and hygiene (WASH) intervention vs no WASH intervention Strongyloides stercoralis prevalence · children and adults Interventions to improve water, sanitation, and hygiene for preventing soil‐transmitted helminth infection (2022) · Cochrane | no estimate extracted | NR | No studies |
Antiplatelet therapy vs placebo Major bleeding (intracranial and extracranial) · s for prevention of cognitive decline and dementia in people with cerebral small vessel disease and no dementia Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but… (2022) · Cochrane | no estimate extracted | NR | No studies |
Dual antiplatelet therapy vs single antiplatelet therapy Incident dementia · people with cerebral small vessel disease and no dementia Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but… (2022) · Cochrane | no estimate extracted | NR | No studies |
Dual antiplatelet therapy vs single antiplatelet therapy Functional ability · people with cerebral small vessel disease and no dementia Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but… (2022) · Cochrane | no estimate extracted | NR | No studies |
Antiplatelet drug vs placebo Incident dementia · s with mixed prevalence of antiplatelet drug use at baseline, for the prevention of cognitive decline and dementia in… Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but… (2022) · Cochrane | no estimate extracted | NR | No studies |
Dual antiplatelet therapy vs single antiplatelet therapy Any adverse events (excluding major bleeding) · people with cerebral small vessel disease and no dementia Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but… (2022) · Cochrane | no estimate extracted | NR | No studies |
Antiplatelet therapy vs placebo Incident dementia · s for prevention of cognitive decline and dementia in people with cerebral small vessel disease and no dementia Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but… (2022) · Cochrane | no estimate extracted | NR | No studies |
Chronic DVT ‐ antiplatelet agents plus BMP vs BMP alone Post‐thrombotic syndrome · people requiring treatment for chronic DVT Antiplatelet agents for the treatment of deep venous thrombosis (2022) · Cochrane | no estimate extracted | NR | No studies |
Chronic DVT ‐ antiplatelet agents plus BMP vs BMP plus placebo Post‐thrombotic syndrome · people requiring treatment for chronic DVT Antiplatelet agents for the treatment of deep venous thrombosis (2022) · Cochrane | no estimate extracted | NR | No studies |
Progesterone vs no treatment or placebo (route of progesterone administration) Outcomes* · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Progesterone vs placebo/no treatment Adverse events, OHSS, preterm delivery, congenital anomaly · women with gonadotropin stimulation Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Progesterone vs placebo/no treatment Live birth rate · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Progesterone vs placebo/no treatment Adverse events, OHSS, preterm delivery, congenital anomaly · women with gonadotropin plus oral (clomiphene citrate or letrozole) stimulation Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Progesterone vs placebo/no treatment Adverse events, OHSS, preterm delivery, congenital anomaly · women with oral (clomiphene citrate or letrozole) stimulation Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Intramuscular (IM) progesterone vs vaginal progesterone Live birth rate · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Intramuscular (IM) progesterone vs vaginal progesterone Multiple pregnancy rate · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Intramuscular (IM) progesterone vs vaginal progesterone OHSS, preterm delivery, congenital anomaly · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Oral progesterone vs vaginal progesterone Live birth rate · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Oral progesterone vs vaginal progesterone Multiple pregnancy rate · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Oral progesterone vs vaginal progesterone Adverse events, OHSS, preterm delivery, congenital anomaly · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous (Sc) gonadotropin‐releasing hormone (GnRH) agonist vs placebo/no treatment Live birth · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous (Sc) gonadotropin‐releasing hormone (GnRH) agonist vs placebo/no treatment Adverse events, OHSS, preterm delivery, congenital anomaly · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Progesterone vs no treatment or placebo (route of progesterone administration) Adverse events, OHSS, preterm delivery, congenital anomaly · women trying to conceive by intrauterine insemination Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2022) · Cochrane | no estimate extracted | NR | No studies |
Systemic corticosteroids vs placebo Participants who underwent surgery · people with non‐radicular low back pain Systemic corticosteroids for radicular and non‐radicular low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Systemic corticosteroids vs placebo Participants who experienced a serious adverse event · people with non‐radicular low back pain Systemic corticosteroids for radicular and non‐radicular low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Systemic corticosteroids vs placebo Participants who experienced any adverse event · people with spinal stenosis Systemic corticosteroids for radicular and non‐radicular low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |